Recent 8-K filings for LENZ

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 20:07 UTC earnings item 2.02item 9.01

  LENZ Therapeutics reports Q1 2026 net loss $41.5M, VIZZ product sales $1.7M

source · LENZ on sec.gov